Polyhexanide 0.2% in treatment of trophic foot ulcers in leprosy - preliminary study
AUTOR(ES)
Zanchin, Túlio Neutzling, Serafini, Cássio Battisti, Brandão, Francine Silva, Nery, José Augusto da Costa
FONTE
An. Bras. Dermatol.
DATA DE PUBLICAÇÃO
2018-02
RESUMO
Abstract: Leprosy is a chronic infectious disease caused by Mycobacterium leprae, which affects peripheral nerves, skin and mucous membranes. The impairment of neural function as well as sensory or sensory-motor disabilities in leprosy continue to be a problem that requires careful attention in the management of patients with the aim to avoid or minimize their progression to prevent sequelae. One of the most common characteristics of these ulcers is the tendency to chronicity, with variable therapeutic response. In this article, we shall discuss the therapeutic management of thirteen trophic leprosy ulcers in eight patients using polyhexanide 0.2% products.
Documentos Relacionados
- Double-masked cross-over comparison of Ganda 1.02 (guanethidine 1% and adrenaline 0.2% mixture) with gutt. adrenaline 1% (Simplene 1%) and with pilocarpine 1% (Sno-Pilo 1%).
- Pulse Pressure and Prediction of Incident Foot Ulcers in Type 2 Diabetes
- Excitons em Sistemas Quânticos 0-2D
- Evaluation of healing of pressure ulcers through thermography: a preliminary study
- A system for treatment of diabetic foot ulcers using led irradiation and natural latex
